BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18501999)

  • 1. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Lin HH; Liao HW; Lin SK; Wang LY
    Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
    Wang LY; Lin HH
    J Hepatol; 2007 Jun; 46(6):1018-25. PubMed ID: 17399842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago.
    Wang LY; Lin HH
    Vaccine; 2007 Oct; 25(41):7160-7. PubMed ID: 17707557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
    Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
    Lu CY; Ni YH; Chiang BL; Chen PJ; Chang MH; Chang LY; Su IJ; Kuo HS; Huang LM; Chen DS; Lee CY
    J Infect Dis; 2008 May; 197(10):1419-26. PubMed ID: 18444799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination.
    Su FH; Cheng SH; Li CY; Chen JD; Hsiao CY; Chien CC; Yang YC; Hung HH; Chu FY
    Vaccine; 2007 Nov; 25(47):8085-90. PubMed ID: 17920732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
    Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.
    Wu TW; Chen CF; Lai SK; Lin HH; Chu CC; Wang LY
    J Gastroenterol Hepatol; 2015 May; 30(5):891-9. PubMed ID: 25389088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.
    Boxall EH; A Sira J; El-Shuhkri N; Kelly DA
    J Infect Dis; 2004 Oct; 190(7):1264-9. PubMed ID: 15346336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.